Your browser doesn't support javascript.
loading
Re: FGFR Inhibition Augments Anti-PD-1 Efficacy in Murine FGFR3-mutant Bladder Cancer by Abrogating Immunosuppression.
St-Laurent, Marie-Pier; Black, Peter C.
Affiliation
  • St-Laurent MP; Department of Urologic Sciences, University of British Columbia, Vancouver, Canada. Electronic address: mst-laurent@prostatecentre.com.
  • Black PC; Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.
Eur Urol ; 86(2): 184-185, 2024 Aug.
Article in En | MEDLINE | ID: mdl-38614823

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Receptor, Fibroblast Growth Factor, Type 3 Limits: Animals Language: En Journal: Eur Urol Year: 2024 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Receptor, Fibroblast Growth Factor, Type 3 Limits: Animals Language: En Journal: Eur Urol Year: 2024 Document type: Article Country of publication: